ArticleUnited European gastroenterology journal2021

Ustekinumab is more effective than azathioprine to prevent endoscopic postoperative recurrence in Crohn's disease.

Anthony Buisson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.